Femasys Inc. (FEMY) vs Nephros Inc. (NEPH)
Femasys Inc. and Nephros Inc. are both Medical Instruments & Supplies companies. Nephros Inc. is the larger, with a market value of $45.0M against $20.4M — 2.2× the size. Femasys Inc. has negative trailing earnings, so its P/E is not meaningful; Nephros Inc. trades at 27.2×. Nephros Inc. grew revenue faster over the last twelve months: 24.2% against 21.9%. Nephros Inc. has the higher net margin (8.38% vs −534.3%) and the higher return on invested capital (14.1% vs −176.9%). Across the 18 metrics below, Nephros Inc. leads on 16 and Femasys Inc. on 2.
Valuation
Profitability
| Metric | FEMY | NEPH | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 60.95% | 61.26% | 54.62% |
| Operating margin | (763.90%) | 7.92% | 1.64% |
| Net margin | (534.27%) | 8.38% | 0.00% |
| Free cash flow margin | (786.02%) | (3.19%) | 1.61% |
| Return on equity | (443.65%) | 16.10% | 0.00% |
| Return on assets | (94.25%) | 12.39% | 0.00% |
| Return on invested capital | (176.91%) | 14.11% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack